Answers are grounded in this paper and cite their sources.
This review provides information on risk stratification and therapeutic options for managing hypertrophic cardiomyopathy.
PREVIEWThe annual incidence of sudden death in patients who have hypertrophic cardiomyopathy is estimated to be 6% in young adults and 1% in the elderly. Because there is no cure for this disease, it is important to determir the patient’s risk factors and provide appropriate treatment and counselint In this article, Drs DeLuca and Tak provide invaluable information about risk stratification and offer therapeutic options for monitoring disease and alleviating symptoms.
No takes yet. Share an insight, caveat, or question.
DeLuca et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: